{
    "ticker": "FLGT",
    "name": "Fulgent Genetics, Inc.",
    "description": "Fulgent Genetics, Inc. is a leading technology company focused on innovative diagnostic solutions, particularly in the field of genetic testing. Founded in 2011 and headquartered in Temple City, California, Fulgent has established itself as a key player in the rapidly evolving landscape of genomics and personalized medicine. The company offers a wide array of genetic testing services, including comprehensive testing panels for hereditary cancer, infectious diseases, and carrier screening. Utilizing advanced technology and bioinformatics, Fulgent provides healthcare professionals with accurate, reliable, and actionable genetic information. Their proprietary platform allows for customizable testing options, enabling clinicians to tailor diagnostics to their patients' specific needs. Fulgent's commitment to continuous innovation is reflected in its active pursuit of new test development and enhancements to its existing offerings. The company aims to improve patient outcomes through early diagnosis and informed treatment decisions. In addition to its testing services, Fulgent is dedicated to advancing the field of genetics through research collaborations and partnerships with academic institutions and healthcare organizations. The company\u2019s mission is to make genetic testing accessible and understandable, empowering patients and providers alike to leverage genetic insights in healthcare.",
    "industry": [
        "Healthcare",
        "Genomics"
    ],
    "headquarters": "Temple City, California, USA",
    "founded": "2011",
    "website": "https://www.fulgentgenetics.com",
    "ceo": "Chenming Hu",
    "social_media": {
        "twitter": "https://twitter.com/FulgentGenetics",
        "linkedin": "https://www.linkedin.com/company/fulgent-genetics"
    },
    "investor_relations": "https://ir.fulgentgenetics.com",
    "key_executives": [
        {
            "name": "Chenming Hu",
            "position": "CEO"
        },
        {
            "name": "Thomas A. McGinn",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "Genetic Testing",
            "products": [
                "Hereditary Cancer Testing",
                "Infectious Disease Testing",
                "Carrier Screening"
            ]
        }
    ],
    "seo": {
        "meta_title": "Fulgent Genetics, Inc. | Innovative Genetic Testing Solutions",
        "meta_description": "Explore Fulgent Genetics, Inc., a leader in genetic testing and diagnostics. Discover their innovative services and commitment to improving healthcare.",
        "keywords": [
            "Fulgent Genetics",
            "Genetic Testing",
            "Healthcare",
            "Personalized Medicine",
            "Genomics"
        ]
    },
    "faq": [
        {
            "question": "What services does Fulgent Genetics offer?",
            "answer": "Fulgent Genetics offers a variety of genetic testing services, including hereditary cancer testing, infectious disease testing, and carrier screening."
        },
        {
            "question": "Who is the CEO of Fulgent Genetics?",
            "answer": "Chenming Hu is the CEO of Fulgent Genetics, Inc."
        },
        {
            "question": "Where is Fulgent Genetics headquartered?",
            "answer": "Fulgent Genetics is headquartered in Temple City, California, USA."
        },
        {
            "question": "When was Fulgent Genetics founded?",
            "answer": "Fulgent Genetics was founded in 2011."
        }
    ],
    "competitors": [
        "NTRA",
        "GHDX",
        "ILMN"
    ],
    "related_stocks": [
        "AMGN",
        "REGN",
        "ABT",
        "BMY"
    ]
}